{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:26:01Z","timestamp":1782444361907,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Guilan and GUMS, Rasht, Iran"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.clineuro.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:57:55Z","timestamp":1525240675000},"page":"84-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma"],"prefix":"10.1016","volume":"170","author":[{"given":"Farhad","family":"Mashayekhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2018.05.001_bib0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the Central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.prp.2006.01.012","article-title":"Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas","volume":"202","author":"von Randow","year":"2006","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","article-title":"Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion","volume":"20","author":"Bourboulia","year":"2010","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.7754\/Clin.Lab.2017.170339","article-title":"Imbalance between matrix metalloproteinases and tissue inhibitors of metalloproteinases promotes invasion and metastasis of head and neck squamous cell carcinoma","volume":"63","author":"Stanciu","year":"2017","journal-title":"Clin. Lab."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0025","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.2147\/OTT.S99580","article-title":"Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction","volume":"9","author":"Lu","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Vascular remodeling, and vascular disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0035","first-page":"38","article-title":"Association of MMP-9 promoter polymorphism and breast cancer among Iranian patients","volume":"22","author":"Toroghi","year":"2017","journal-title":"Eur. J. Oncol."},{"issue":"April","key":"10.1016\/j.clineuro.2018.05.001_bib0040","article-title":"Genetic dimension of intervertebral disc degeneration: polymorphism of matrix metalloproteinase 1 and 3 in the North Iranian population","volume":"4","author":"Saberi","year":"2017","journal-title":"Turk. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0045","first-page":"46","article-title":"Association between MMP9 promoter polymorphism and breast cancer progression in Northwest of Iran","volume":"19","author":"Toroghi","year":"2016","journal-title":"Amuj"},{"key":"10.1016\/j.clineuro.2018.05.001_bib0050","first-page":"64","article-title":"The relationship between MMP-9 promoterpolymorphism and IVF outcome","volume":"61","author":"Shabanipour","year":"2015","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.clineuro.2018.05.001_bib0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.5483\/BMBRep.2012.45.11.233","article-title":"Expression level and glycan dynamics determine the net effects of TIMP-1 on cancer progression","volume":"45","author":"Kim","year":"2012","journal-title":"BMB Rep."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0060","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jnr.10835","article-title":"Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system","volume":"74","author":"Gardner","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/med-2016-0032","article-title":"Meningioma recurrence","volume":"11","author":"Hortob\u00e1gyi","year":"2016","journal-title":"Open Med. (Wars)"},{"key":"10.1016\/j.clineuro.2018.05.001_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","article-title":"Meningioma pathology, genetics, and biology","volume":"63","author":"Lamszus","year":"2004","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clineuro.2017.05.002","article-title":"Genetic and epigenetic alterations in meningiomas","volume":"157","author":"Galani","year":"2017","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10014-016-0271-7","article-title":"Genetic landscape of meningioma","volume":"33","author":"Yuzawa","year":"2016","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/09674845.2017.1396677","article-title":"Functional variants of p21 gene alter susceptibility to meningioma","volume":"75","author":"Mashayekhi","year":"2018","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00280-012-2057-x","article-title":"Immunohistochemical study of MRP5 expression in meningiomas","volume":"71","author":"Alexiou","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cancergencyto.2005.04.003","article-title":"Inactivation patterns of NF2 and DAL-1\/4.1B (EPB41L3) in sporadic meningioma","volume":"162","author":"Nunes","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.20733","article-title":"Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression","volume":"114","author":"Wrobel","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clineuro.2018.05.001_bib0105","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3892\/ijo.2016.3739","article-title":"Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma","volume":"49","author":"Rooprai","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0110","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","article-title":"Hypermethylation and transcriptional down-regulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas","volume":"20","author":"Barski","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0115","first-page":"1039","article-title":"RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis","volume":"31","author":"Tummalapalli","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3171\/2014.8.JNS13515","article-title":"Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas","volume":"121","author":"Coven","year":"2014","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0125","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/cncr.22130","volume":"107","author":"Okuducu","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.05.001_bib0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.29252\/nirp.cjns.4.12.24","article-title":"Expression of matrix metalloproteinase-2 and -9 in meningioma","volume":"4","author":"Mashayekhi","year":"2018","journal-title":"Casp. J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s11064-010-0226-z","article-title":"Cytokine and growth factor concentration in cerebrospinal fluid from patients with hydrocephalus following endovascular embolization of unruptured aneurysms in comparison with other types of hydrocephalus","volume":"35","author":"Killer","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-10-80","article-title":"Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels","volume":"10","author":"Li","year":"2013","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3892\/or.2017.5759","article-title":"CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0150","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41598-017-03362-z","article-title":"EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion","volume":"7","author":"Yi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clineuro.2018.05.001_bib0155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1006760632766","article-title":"Expression of matrix metalloproteinases and their inhibitors in human brain tumors","volume":"17","author":"Kachra","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.clineuro.2018.05.001_bib0160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13014-015-0475-8","article-title":"Sub-lethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model","volume":"10","author":"Pei","year":"2015","journal-title":"Radiat. Oncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718301756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718301756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T12:21:50Z","timestamp":1604233310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846718301756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":32,"alternative-id":["S0303846718301756"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.05.001","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum TIMP1 and TIMP2 concentration in patients with different grades of meningioma","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}